IOVANCE BIOTHERAPEUTICS, INC. Investment Income, Interest
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Investment Income, Interest of $3.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. investment income, interest for the quarter ending 2026-06-30 was $3.22M, a 21.61% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. investment income, interest for the quarter ending 2026-03-31 was $1.33M, a 58.60% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. investment income, interest for the quarter ending 2025-12-31 was $1.74M, a 81.83% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. investment income, interest for the quarter ending 2025-09-30 was $1.24M, a 68.96% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. investment income, interest for fiscal 2025 was $10.31M, a 49.16% decline from fiscal 2024.
- IOVANCE BIOTHERAPEUTICS, INC. investment income, interest for fiscal 2024 was $20.27M, a 55.43% increase from fiscal 2023.
- IOVANCE BIOTHERAPEUTICS, INC. investment income, interest for fiscal 2023 was $13.04M, a 336.95% increase from fiscal 2022.
- IOVANCE BIOTHERAPEUTICS, INC. investment income, interest for fiscal 2022 was $2.98M, a 561.86% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.22M 10-Q · filed 2026-08-06 | $4.55M 10-Q · filed 2026-08-06 | $6.29M derived: sum of 3 quarters · filed 2026-08-06 | $7.53M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.33M 10-Q · filed 2026-05-07 | $3.07M derived: sum of 2 quarters · filed 2026-05-07 | $4.32M derived: sum of 3 quarters · filed 2026-05-07 | $8.42M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.98M derived: sum of 2 quarters · filed 2026-02-24 | $7.09M derived: sum of 3 quarters · filed 2026-08-06 | $10.31M 10-K · filed 2026-02-24 |
| 2025-09-30 | $1.24M 10-Q · filed 2025-11-06 | $5.35M derived: sum of 2 quarters · filed 2026-08-06 | $8.57M 10-Q · filed 2025-11-06 | $18.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $4.10M 10-Q · filed 2026-08-06 | $7.32M 10-Q · filed 2026-08-06 | $16.90M derived: sum of 3 quarters · filed 2026-08-06 | $20.90M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $3.22M 10-Q · filed 2026-05-07 | $12.79M derived: sum of 2 quarters · filed 2026-05-07 | $16.80M derived: sum of 3 quarters · filed 2026-05-07 | $20.16M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $9.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $13.58M derived: sum of 2 quarters · filed 2026-02-24 | $16.93M derived: sum of 3 quarters · filed 2026-02-24 | $20.27M 10-K · filed 2026-02-24 |
| 2024-09-30 | $4.00M 10-Q · filed 2025-11-06 | $7.36M derived: sum of 2 quarters · filed 2025-11-06 | $10.70M 10-Q · filed 2025-11-06 | $13.82M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $3.35M 10-Q · filed 2025-08-07 | $6.69M 10-Q · filed 2025-08-07 | $9.81M derived: sum of 3 quarters · filed 2026-02-24 | $13.17M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $3.34M 10-Q · filed 2025-05-08 | $6.46M derived: sum of 2 quarters · filed 2026-02-24 | $9.81M derived: sum of 3 quarters · filed 2026-02-24 | $12.89M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $6.48M derived: sum of 2 quarters · filed 2026-02-24 | $9.56M derived: sum of 3 quarters · filed 2026-02-24 | $13.04M 10-K · filed 2026-02-24 |
| 2023-09-30 | $3.36M 10-Q · filed 2024-11-07 | $6.44M derived: sum of 2 quarters · filed 2024-11-07 | $9.93M 10-Q · filed 2024-11-07 | $11.64M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $3.08M 10-Q · filed 2024-08-08 | $6.57M 10-Q · filed 2024-08-08 | $8.28M derived: sum of 3 quarters · filed 2025-02-27 | $9.06M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $3.49M 10-Q · filed 2024-05-09 | $5.20M derived: sum of 2 quarters · filed 2025-02-27 | $5.98M derived: sum of 3 quarters · filed 2025-02-27 | $6.37M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.49M derived: sum of 2 quarters · filed 2025-02-27 | $2.88M derived: sum of 3 quarters · filed 2025-02-27 | $2.98M 10-K · filed 2025-02-27 |
| 2022-09-30 | $777.00K 10-Q · filed 2023-11-07 | $1.16M derived: sum of 2 quarters · filed 2023-11-07 | $1.27M 10-Q · filed 2023-11-07 | $1.40M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $385.00K 10-Q · filed 2023-08-08 | $491.00K 10-Q · filed 2023-08-08 | $626.00K derived: sum of 3 quarters · filed 2024-02-28 | $746.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $106.00K 10-Q · filed 2023-05-10 | $241.00K derived: sum of 2 quarters · filed 2024-02-28 | $361.00K derived: sum of 3 quarters · filed 2024-02-28 | $436.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $255.00K derived: sum of 2 quarters · filed 2024-02-28 | $330.00K derived: sum of 3 quarters · filed 2024-02-28 | $451.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $120.00K 10-Q · filed 2022-11-03 | $195.00K derived: sum of 2 quarters · filed 2022-11-03 | $316.00K 10-Q · filed 2022-11-03 | $453.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $75.00K 10-Q · filed 2022-08-04 | $196.00K 10-Q · filed 2022-08-04 | $333.00K derived: sum of 3 quarters · filed 2023-02-28 | $728.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $121.00K 10-Q · filed 2022-05-05 | $258.00K derived: sum of 2 quarters · filed 2023-02-28 | $653.00K derived: sum of 3 quarters · filed 2023-02-28 | $1.26M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $532.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.14M derived: sum of 3 quarters · filed 2023-02-28 | $2.36M 10-K · filed 2023-02-28 |
| 2020-09-30 | $395.00K 10-Q · filed 2021-11-04 | $1.00M derived: sum of 2 quarters · filed 2021-11-04 | $2.22M 10-Q · filed 2021-11-04 | $3.76M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $609.00K 10-Q · filed 2021-08-05 | $1.82M 10-Q · filed 2021-08-05 | $3.37M derived: sum of 3 quarters · filed 2022-02-24 | $5.49M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $1.22M 10-Q · filed 2021-05-06 | $2.76M derived: sum of 2 quarters · filed 2022-02-24 | $4.88M derived: sum of 3 quarters · filed 2022-02-24 | $7.50M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $3.67M derived: sum of 2 quarters · filed 2022-02-24 | $6.28M derived: sum of 3 quarters · filed 2022-02-24 | $9.32M 10-K · filed 2022-02-24 |
| 2019-09-30 | $2.12M 10-Q · filed 2020-11-05 | $4.74M derived: sum of 2 quarters · filed 2020-11-05 | $7.77M 10-Q · filed 2020-11-05 | $10.14M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $2.61M 10-Q · filed 2020-08-06 | $5.65M 10-Q · filed 2020-08-06 | $8.02M derived: sum of 3 quarters · filed 2021-02-25 | $9.25M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $3.04M 10-Q · filed 2020-05-05 | $5.40M derived: sum of 2 quarters · filed 2021-02-25 | $6.63M derived: sum of 3 quarters · filed 2021-02-25 | $7.35M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.60M derived: sum of 2 quarters · filed 2021-02-25 | $4.32M derived: sum of 3 quarters · filed 2021-02-25 | $4.68M 10-K · filed 2021-02-25 |
| 2018-09-30 | $1.23M 10-Q · filed 2019-11-04 | $1.95M derived: sum of 2 quarters · filed 2019-11-04 | $2.31M 10-Q · filed 2019-11-04 | $2.53M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $718.00K 10-Q · filed 2019-08-01 | $1.08M 10-Q · filed 2019-08-01 | $1.30M derived: sum of 3 quarters · filed 2020-02-25 | $1.49M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $362.00K 10-Q · filed 2019-05-07 | $579.00K derived: sum of 2 quarters · filed 2020-02-25 | $773.00K derived: sum of 3 quarters · filed 2020-02-25 | $977.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $217.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $411.00K derived: sum of 2 quarters · filed 2020-02-25 | $615.00K derived: sum of 3 quarters · filed 2020-02-25 | $813.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $194.00K 10-Q · filed 2018-11-06 | $398.00K derived: sum of 2 quarters · filed 2018-11-06 | $596.00K 10-Q · filed 2018-11-06 | $830.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $204.00K 10-Q · filed 2018-08-07 | $403.00K 10-Q · filed 2018-08-07 | $636.00K derived: sum of 3 quarters · filed 2019-02-28 | $857.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $198.00K 10-Q · filed 2018-05-10 | $432.00K derived: sum of 2 quarters · filed 2019-02-28 | $653.00K derived: sum of 3 quarters · filed 2019-02-28 | $817.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $455.00K derived: sum of 2 quarters · filed 2019-02-28 | $619.00K derived: sum of 3 quarters · filed 2019-02-28 | $745.00K 10-K · filed 2019-02-28 |
| 2016-09-30 | $221.00K 10-Q · filed 2017-11-02 | $385.00K derived: sum of 2 quarters · filed 2017-11-02 | $511.00K 10-Q · filed 2017-11-02 | $588.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $164.00K 10-Q · filed 2017-08-03 | $290.00K 10-Q · filed 2017-08-03 | $367.00K derived: sum of 3 quarters · filed 2018-03-12 | $375.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $126.00K 10-Q · filed 2017-05-03 | $203.00K derived: sum of 2 quarters · filed 2018-03-12 | $211.00K derived: sum of 3 quarters · filed 2018-03-12 | $283.74K derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $85.00K derived: sum of 2 quarters · filed 2018-03-12 | $157.74K derived: sum of 3 quarters · filed 2018-03-12 | $200.00K 10-K · filed 2018-03-12 |
| 2015-09-30 | $8.00K 10-Q · filed 2015-11-06 | $80.73K derived: sum of 2 quarters · filed 2015-11-06 | $123.00K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $72.73K 10-Q · filed 2015-08-10 | $72.73K 10-Q · filed 2015-08-10 | ||
| 2014-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $6.00K derived: sum of 2 quarters · filed 2017-03-09 | $6.00K 10-K · filed 2017-03-09 | |
| 2014-09-30 | $5.00K 10-Q · filed 2015-11-06 | $5.00K 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |